Wall Street expects a year-over-year decline in earnings on higher revenues when Humana (HUM) reports results for the quarter ended September 2024. While this widely-known consensus outlook is ...

In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against the other oversold growth stocks. As investors focus on consumer spending in a bid to assess the broader ...

A sharp decline in its Medicare Star Ratings for 2025 has prompted Humana (NYSE:HUM) to file a lawsuit in a Texas federal court, seeking a reversal of the cut, Bloomberg News reported Saturday.